Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Choosing the right credit card for cash back can boost your savings. Explore options that deliver the best return on your spending.
25,914 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
A fabless chip ETF is up sharply this year, powered by AI-driven design firms and a deliberate omission of Intel. The...
Gas costs ripple through every link of retail, from trucking to checkout. This article breaks down how could sudden j...
Snowflake reports a sizable rise in remaining performance obligations, underscoring a strengthening data-backlog thes...
Leveraged ETFs like TQQQ and QLD promise amplified Nasdaq-100 exposure, but they come with unique risks and timing re...
New York’s decision to pause large-scale data center projects up to a year changes the playing field for cloud giants...
Two popular 3x ETFs chase daily moves in different corners of the market. This guide breaks down when levered bets on...
AI-driven capex is lifting lithography demand, placing ASML at the center of a multiyear upgrade cycle. This piece ex...
The White House extended the deadline for Iran to reopen the Strait of Hormuz to April 6, sparking a fresh wave of oi...
At CES 2026, Jensen Huang highlighted memory as AI's key bottleneck. This shift sent memory stocks like Micron and Sa...
Amazon is betting big on hardware to power AI at scale. This article explains how amazon's chips driving growth in AI...
Cardano has struggled to deliver on big promises, leaving many investors looking for cryptocurrencies that better buy...